BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2936163)

  • 1. Platelet function and platelet-polymorphonuclear-neutrophil interaction in patients with deficient platelet lipoxygenase activity.
    Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():533-6. PubMed ID: 2936163
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation.
    Bazzoni G; Dejana E; Del Maschio A
    Haematologica; 1991; 76(6):491-9. PubMed ID: 1820986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet lipoxygenase activity: a possible indicator for marrow engraftment in lipoxygenase-deficient patients.
    Okuma M; Takayama H; Sawada H; Kita K; Uchino H
    N Engl J Med; 1983 Mar; 308(13):778-9. PubMed ID: 6402703
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of polymorphonuclear leukocyte function by platelets.
    Aziz KA; Zuzel M
    Saudi Med J; 2001 Jun; 22(6):526-30. PubMed ID: 11426246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between platelets and neutrophils in the eicosanoid pathway.
    Marcus AJ; Safier LB; Ullman HL; Islam N; Broekman MJ; Falck JR; Fischer S; Santos MT; Valles J; von Schacky C
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():263-6. PubMed ID: 2526482
    [No Abstract]   [Full Text] [Related]  

  • 6. Icosanoid production during platelet-neutrophil interactions.
    Marcus AJ; Safier LB; Ullman HL; Broekman MJ; Islam N; Oglesby TD; Gorman RR; Ward JW
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():527-32. PubMed ID: 2936161
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
    Schafer AI
    N Engl J Med; 1982 Feb; 306(7):381-6. PubMed ID: 6799826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils inhibit platelet reactivity by multiple mechanisms: relevance to thromboregulation.
    Marcus AJ
    J Lab Clin Med; 1990 Aug; 116(2):138-9. PubMed ID: 2394936
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymorphonuclear leucocyte-dependent modulation of platelet function: relevance to the pathogenesis of thrombosis.
    Cerletti C; Evangelista V; De Gaetano G
    Pharmacol Res; 1992; 26(3):261-8. PubMed ID: 1437990
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative changes of hydroxyacid formation during platelet-neutrophil interaction.
    Maderna P; Colli S; Caruso D; Eligini S; Toia A; Galli G; Tremoli E
    J Lab Clin Med; 1993 Mar; 121(3):406-14. PubMed ID: 8383163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation.
    Abou-Saleh H; Théorêt JF; Yacoub D; Merhi Y
    Thromb Haemost; 2005 Dec; 94(6):1230-5. PubMed ID: 16411399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
    Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
    Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Defects in the prostaglandin system. IX. Lipoxygenase defect of thrombocytes in a patient with polycythemia vera].
    Sinzinger H; Gisslinger H; Linkesch W; Peskar BA
    Wien Klin Wochenschr; 1990 Feb; 102(3):74-6. PubMed ID: 2107637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of copper-aspirin complex on platelet-neutrophil interactions.
    Shen ZQ; Chen P; Li L; Chen P; Liu WP
    Acta Pharmacol Sin; 2004 May; 25(5):576-80. PubMed ID: 15132821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional modulation of platelet and polymorphonuclear leukocyte activities.
    Del Maschio A; Dejana E; Bazzoni G
    Ann Hematol; 1993 Jul; 67(1):23-31. PubMed ID: 8334196
    [No Abstract]   [Full Text] [Related]  

  • 16. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
    Schumacher HR; Kos JR
    N Engl J Med; 1982 Aug; 307(6):378-9. PubMed ID: 6806661
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adherent reaction among activated platelets, polymorphonuclear cells and vascular endothelial cells under thrombin stimulation or shear stress].
    Kageoka T; Kanekuni Y; Ueta T; Ogura K; Sugihara S; Nishiya K; Yamasaki F
    Rinsho Byori; 1996 Aug; 44(8):757-63. PubMed ID: 8816062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-dependent modulation of neutrophil function.
    Bazzoni G; Dejana E; Del Maschio A
    Pharmacol Res; 1992; 26(3):269-72. PubMed ID: 1437991
    [No Abstract]   [Full Text] [Related]  

  • 20. BW755C, a dual lipoxygenase/cyclooxygenase inhibitor, reduces mural platelet and neutrophil deposition and vasoconstriction after angioplasty injury in pigs.
    Provost P; Merhi Y
    J Pharmacol Exp Ther; 1996 Apr; 277(1):17-21. PubMed ID: 8613915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.